Naturally Splendid Enterprises Ltd., a biotechnology and consumer products company, develops, produces, commercializes, sells, and licenses plant-derived, bioactive ingredients, nutrient dense foods, and related products in North America, Asia, and Europe. The company offers retail hemp superfood products under the Natera brand name; natural and organic hemp products under the Chii brand name; hemp-based pet care products under the Pawsitive FX brand name; plant-derived bulk ingredients under the Natera Ingredients brand name; and lifestyle and healthy meal replacement products under the Elevate Me brand name. It also provides retail hemp based cannabinoid nutraceutical and cosmeceutical products under the Natera CBD brand name; and retail hemp based cosmeceutical products under the Natera Skincare brand name. The company sells food and ingredients to commercial processors and consumers through grocery stores, health and nutrition stores, and online distribution channels. Naturally Splendid Enterprises Ltd. is headquartered in Pitt Meadows, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone604-465-0548
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$3.13 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
Naturally Splendid Enterprises (CVE:NSP) Frequently Asked Questions
What is Naturally Splendid Enterprises' stock symbol?
Naturally Splendid Enterprises trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NSP."
Has Naturally Splendid Enterprises been receiving favorable news coverage?
Headlines about NSP stock have been trending somewhat negative on Sunday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Naturally Splendid Enterprises earned a coverage optimism score of -1.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Naturally Splendid Enterprises.
Who are some of Naturally Splendid Enterprises' key competitors?
Some companies that are related to Naturally Splendid Enterprises include Actinium Pharmaceuticals (ATNM), Biotron (BIT), Immunoprecise Antibodies (IPA), Ixico (IXI), Rhinomed (RNO), Noxopharm (NOX), Nuformix (NFX), Prescient Therapeutics (PTX), ImmuPharma (IMM), Acrux (ACR), Bio-Gene Technology (BGT), Pharmaust (PAA), Memphasys (MEM), Prana Biotechnology (PBT) and Biocardia (BCDA).
What other stocks do shareholders of Naturally Splendid Enterprises own?
Who are Naturally Splendid Enterprises' key executives?
Naturally Splendid Enterprises' management team includes the folowing people:
- Mr. Douglas L. Mason, CEO & Director (Age 71)
- Mr. Jon Craig Goodwin, Founder, Pres & Director
- Mr. Bryan Carson, Co-Founder, Exec. VP of Marketing & Innovation and Director
- Jennifer Hanson, Sec.
- Mr. Sead Hamzagic, Chief Financial Officer
How do I buy shares of Naturally Splendid Enterprises?
Shares of NSP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Naturally Splendid Enterprises' stock price today?
One share of NSP stock can currently be purchased for approximately C$0.07.
How big of a company is Naturally Splendid Enterprises?
What is Naturally Splendid Enterprises' official website?
How can I contact Naturally Splendid Enterprises?
The company can be reached via phone at 604-465-0548.
MarketBeat Community Rating for Naturally Splendid Enterprises (CVE NSP)
MarketBeat's community ratings are surveys of what our community members think about Naturally Splendid Enterprises and other stocks. Vote "Outperform" if you believe NSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
